Peritoneal sarcoma is a rare cancer that develops when abnormal cells form tumors within or spread to the peritoneum, the thin tissue lining that covers the inside of the abdomen and protects abdominal organs. Understanding how this disease is diagnosed is essential for getting the right care at the right time.

Introduction: Who Should Seek Diagnostic Testing

People experiencing certain symptoms should consider seeking medical evaluation for possible peritoneal sarcoma. The disease often goes unnoticed in early stages because symptoms tend to be vague and can easily be mistaken for other, less serious conditions. This delay in recognition means that many people don’t realize something is wrong until the disease has already progressed considerably.^[1]

Anyone noticing a noticeable lump or mass in the abdomen should consult a doctor promptly. Other warning signs include persistent abdominal swelling or bloating that doesn’t improve with dietary changes or exercise, ongoing dull pain or pressure in the abdomen or back, and unexpectedly feeling full after eating only small amounts of food. Some people may experience weight loss without trying, persistent fatigue that doesn’t improve with rest, or changes in bowel habits such as increased constipation.^[1][3]

For retroperitoneal sarcomas, which occur in the space behind the peritoneum, symptoms often don’t appear until the tumor has grown quite large. Retroperitoneal sarcomas smaller than five centimeters are rarely detected because patients typically don’t notice them until they’ve become much larger. These tumors can sometimes press against or touch surrounding organs, leading to symptoms related to the affected structures.^[6][11]

Classic Diagnostic Methods

The path to diagnosing peritoneal sarcoma typically begins with a comprehensive physical examination. During this exam, your doctor will carefully feel your abdomen, checking for any abnormal lumps, masses, or areas of swelling. They may also assess whether fluid has accumulated in your abdominal cavity, a condition known as ascites, which can sometimes be detected by feeling and examining the abdomen’s shape and response to pressure.^[3][4]

Imaging Tests

Imaging studies form the cornerstone of peritoneal sarcoma diagnosis. These tests create detailed pictures of the inside of your body, allowing doctors to see structures that can’t be felt during a physical exam. A computed tomography (CT) scan is typically the first and most valuable imaging test for diagnosing retroperitoneal sarcoma and assessing peritoneal involvement. The CT scan uses X-rays taken from multiple angles and combines them with computer processing to create cross-sectional images of your bones, blood vessels, and soft tissues.^[6][11]

Magnetic resonance imaging (MRI) is another powerful diagnostic tool that uses magnetic fields and radio waves instead of X-rays to create detailed images of your body’s soft tissues. Both CT and MRI scans help doctors identify where tumors are located, how large they are, and whether they appear to be affecting nearby organs. These scans are essential for evaluating the extent of disease throughout the abdomen and planning treatment approaches.^[4][10]

Some patients may also undergo a PET-CT scan, which combines the functional information from a positron emission tomography (PET) scan with the structural detail of a CT scan. This hybrid imaging technique can be particularly useful because it shows both the anatomy and metabolic activity of tissues, helping doctors distinguish between active cancer and normal tissue.^[4]

However, it’s important to understand that imaging tests have limitations when it comes to peritoneal cancer. These scans are often not sensitive enough to detect smaller cancers or early peritoneal disease. Cancer that has spread across the abdominal lining may not form distinct masses that show up clearly on scans. Therefore, a negative or normal-looking scan does not completely rule out the presence of peritoneal disease.^[10][16]

Blood Tests

Blood tests play a supporting role in the diagnostic process. Doctors may order tumor marker tests, which look for specific chemicals in your blood that cancer cells may release. When levels of certain proteins are elevated, it can suggest the presence of peritoneal cancer, though high levels can also occur for other reasons. This means tumor marker tests alone cannot confirm a diagnosis but provide helpful information when considered alongside other test results.^[4][10]

A newer type of blood test called circulating tumor DNA (ctDNA) testing looks for tiny pieces of DNA that cancer cells shed into the bloodstream. This innovative approach can sometimes detect peritoneal cancer that doesn’t show up clearly on imaging scans, though it is still an evolving technology.^[10][16]

Biopsy Procedures

A definitive diagnosis of peritoneal sarcoma requires examining actual tissue samples under a microscope, a process called a biopsy. For peritoneal and retroperitoneal sarcomas, doctors typically perform a core needle biopsy, which uses a hollow needle to remove a small cylinder of tissue from the suspicious area. This procedure is usually done with image guidance, meaning doctors use ultrasound or CT scanning to see exactly where the needle is going as they insert it.^[3]

The tissue sample is then sent to a specialized doctor called a pathologist who has extensive experience with sarcomas. The pathologist examines the cells under a microscope to determine whether cancer is present and, if so, what specific type of sarcoma it is. This detailed analysis is crucial because different types of sarcomas behave differently and may require different treatment approaches. The biopsy can also help doctors distinguish between a sarcoma and other conditions that might be occurring in the abdomen.^[3]

Surgical Diagnostic Procedures

When imaging and blood tests don’t provide enough information, doctors may recommend surgical procedures to look directly inside the abdominal cavity. Staging laparoscopy is a minimally invasive surgical procedure that involves making small incisions in the abdomen and inserting a thin tube with a tiny camera attached. This allows healthcare professionals to visually inspect the peritoneum, identify hidden tumors that are too small to show up on scans, and take tissue or fluid samples for testing.^[10][16]

Another diagnostic surgical technique is peritoneal washing cytology. During a minor surgical procedure, doctors collect fluid from the abdominal cavity and examine it under a microscope, looking for cancer cells floating in the peritoneal fluid. Even when no visible cancer is present to the naked eye, finding cancer cells in the fluid provides strong evidence that cancer has spread to the peritoneum.^[10][16]

Diagnostics for Clinical Trial Qualification

When patients are being considered for participation in clinical trials studying new treatments for peritoneal sarcoma, they typically need to undergo a standardized set of diagnostic tests. These assessments help researchers determine whether a patient meets the specific criteria for the study and provide baseline information that will be used to measure how well the experimental treatment works.

Most clinical trials require comprehensive imaging studies, usually including both CT and MRI scans of the abdomen and pelvis, to document the exact extent and location of cancer throughout the peritoneal cavity. These baseline scans serve as a reference point that researchers will compare to later scans to see whether the tumor has shrunk, stayed the same, or grown during treatment.^[4]

Blood tests are another standard requirement for clinical trial enrollment. In addition to routine blood counts and chemistry panels that assess overall health and organ function, researchers often measure tumor markers at the beginning of the study. Changes in these marker levels over time can provide clues about whether the treatment is working, even before changes show up on imaging scans.^[4]

For certain specialized clinical trials, patients may need tissue from their tumor analyzed for specific genetic features or molecular characteristics. These tests help researchers understand the biology of individual tumors and match patients with treatments most likely to work for their particular type of cancer. The tissue might come from a recent biopsy or, in some cases, from samples saved during a previous surgery.^[5][9]

Some clinical trials may also use a scoring system called the peritoneal cancer index (PCI), which maps exactly where tumors are located in the abdomen and measures their size. This detailed documentation helps researchers understand the severity of disease and determine whether a patient is suitable for certain types of treatment being studied. The PCI involves dividing the abdomen into specific regions and assigning scores based on tumor size in each area.^[19]